Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | August 22, 2023 01:31pm

Gainers

  • Fulcrum Therapeutics (NASDAQ:FULC) stock rose 43.4% to $5.62 during Tuesday's regular session. Fulcrum Therapeutics's stock is trading at a volume of 68.5 million shares as of 13:31 EST. This is 9987.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $347.4 million.
  • Regencell Bioscience (NASDAQ:RGC) shares increased by 28.57% to $18.0. The market value of their outstanding shares is at $234.2 million.
  • CNS Pharma (NASDAQ:CNSP) stock rose 24.81% to $1.52. As of 13:31 EST, this security is trading at a volume of 670.2K shares, making up 152.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.3 million.
  • EUDA Health Holdings (NASDAQ:EUDA) shares increased by 19.1% to $0.94. As of 13:31 EST, EUDA Health Holdings's stock is trading at a volume of 327.3K, which is 191.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $23.0 million.
  • Nanoviricides (AMEX:NNVC) shares moved upwards by 17.75% to $1.64. Trading volume for Nanoviricides's stock is 151.5K as of 13:31 EST. This is 149.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $19.1 million.
  • Renovaro Biosciences (NASDAQ:RENB) shares moved upwards by 13.88% to $2.05. Renovaro Biosciences's stock is trading at a volume of 424.4K shares as of 13:31 EST. This is 11.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $130.5 million.

Losers

  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock fell 29.2% to $0.17 during Tuesday's regular session. As of 13:31 EST, this security is trading at a volume of 4.4 million shares, making up 179.9% of its average full-day volume over the last 100 days. The company's market cap stands at $2.4 million.
  • Aravive (NASDAQ:ARAV) shares fell 25.32% to $0.15. Aravive's stock is trading at a volume of 6.7 million shares as of 13:31 EST. This is 269.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.1 million. As per the press release, Q2 earnings came out yesterday.
  • Armata Pharmaceuticals (AMEX:ARMP) shares declined by 20.92% to $2.85. Armata Pharmaceuticals's stock is trading at a volume of 86.6K shares as of 13:31 EST. This is 53.4% of its average full-day volume over the last 100 days. The company's market cap stands at $103.1 million.
  • Tivic Health Systems (NASDAQ:TIVC) stock declined by 18.65% to $0.05. As of 13:31 EST, this security is trading at a volume of 55.3 million shares, making up 154.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.0 million.
  • Nexalin Technology (NASDAQ:NXL) shares decreased by 18.47% to $0.49. The current volume of 109.0K shares is 432.5% of Nexalin Technology's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $3.6 million.
  • T2 Biosystems (NASDAQ:TTOO) stock declined by 17.11% to $0.44. As of 13:31 EST, this security is trading at a volume of 66.9 million shares, making up 63.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $145.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ARAV ARMP CNSP EUDA FULC NNVC NXL RENB RGC SXTC TIVC TTOO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist